CR20110078A - PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES - Google Patents

PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES

Info

Publication number
CR20110078A
CR20110078A CR20110078A CR20110078A CR20110078A CR 20110078 A CR20110078 A CR 20110078A CR 20110078 A CR20110078 A CR 20110078A CR 20110078 A CR20110078 A CR 20110078A CR 20110078 A CR20110078 A CR 20110078A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutical compositions
somatotrophic
hormones
somatotrophic hormones
composition
Prior art date
Application number
CR20110078A
Other languages
Spanish (es)
Inventor
Andrew Naylor
Andrew Lester Lewis
Lisbeth Illum
Original Assignee
Critical Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39722152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20110078(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Critical Pharmaceuticals Ltd filed Critical Critical Pharmaceuticals Ltd
Publication of CR20110078A publication Critical patent/CR20110078A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende una hormona somatotrófica; un componente polimérico biodegradable; y un modificador de liberación. Tambien se proporciona un proceso para preparar y usar tal composición.The present invention relates to a composition comprising a somatotrophic hormone; a biodegradable polymer component; and a release modifier. A process for preparing and using such a composition is also provided.

CR20110078A 2008-07-11 2011-02-11 PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES CR20110078A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812740.9A GB0812740D0 (en) 2008-07-11 2008-07-11 Composition

Publications (1)

Publication Number Publication Date
CR20110078A true CR20110078A (en) 2011-05-03

Family

ID=39722152

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110078A CR20110078A (en) 2008-07-11 2011-02-11 PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES

Country Status (18)

Country Link
US (1) US20110257097A1 (en)
EP (1) EP2317979A2 (en)
JP (1) JP2011527329A (en)
KR (1) KR20110040892A (en)
CN (1) CN102131498A (en)
AU (1) AU2009269818A1 (en)
BR (1) BRPI0915857A2 (en)
CA (1) CA2730325A1 (en)
CL (1) CL2011000063A1 (en)
CO (1) CO6331422A2 (en)
CR (1) CR20110078A (en)
EA (1) EA201170180A1 (en)
GB (2) GB0812740D0 (en)
IL (1) IL210555A0 (en)
MA (1) MA32545B1 (en)
MX (1) MX2011000259A (en)
WO (1) WO2010004299A2 (en)
ZA (1) ZA201101053B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0812742D0 (en) 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
EP2165919A1 (en) 2008-09-19 2010-03-24 Sika Technology AG Reinforced structure for vehicles
CN101972212A (en) * 2010-10-29 2011-02-16 华侨大学 Method for preparing core-shell type composite microspheres by supercritical fluid technology
EP3202824B1 (en) * 2014-09-29 2021-02-17 LG Hausys, Ltd. Polymer powder and method for preparing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100210509B1 (en) * 1996-01-10 1999-07-15 성재갑 Composition for sustained release of animal growth hormone and method for preparation thereof
US6444223B1 (en) * 1999-05-28 2002-09-03 Alkermes Controlled Therapeutics, Inc. Method of producing submicron particles of a labile agent and use thereof
KR20010002589A (en) * 1999-06-16 2001-01-15 김윤 Process for preparing biodegradable microspheres containing physiologically active agents
KR100622996B1 (en) * 2005-03-03 2006-09-14 한국과학기술원 Nonporous microspheres including drug and manufacturing method thereof
SI2079767T1 (en) * 2006-10-11 2015-01-30 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction

Also Published As

Publication number Publication date
MA32545B1 (en) 2011-08-01
WO2010004299A3 (en) 2010-11-11
AU2009269818A1 (en) 2010-01-14
ZA201101053B (en) 2012-07-25
KR20110040892A (en) 2011-04-20
GB0812740D0 (en) 2008-08-20
CA2730325A1 (en) 2010-01-14
MX2011000259A (en) 2011-04-05
IL210555A0 (en) 2011-03-31
WO2010004299A2 (en) 2010-01-14
US20110257097A1 (en) 2011-10-20
CN102131498A (en) 2011-07-20
CO6331422A2 (en) 2011-10-20
JP2011527329A (en) 2011-10-27
EA201170180A1 (en) 2011-08-30
EP2317979A2 (en) 2011-05-11
GB2474001A (en) 2011-03-30
GB201102015D0 (en) 2011-03-23
CL2011000063A1 (en) 2011-09-23
BRPI0915857A2 (en) 2015-11-03

Similar Documents

Publication Publication Date Title
UY31863A (en) DRUG COMBINATIONS UNDERSTANDING A DGAT INHIBITOR AND A PPAR AGONIST
EA201001555A1 (en) ANTIOXIDATIVE INFLAMMATION MODULATORS: DERIVATIVESIC DERIVATIVES WITH AMINUM AND OTHER MODIFICATIONS OF C-17
JO3172B1 (en) Synthetic bile acid composition,method,and preparation
BRPI0717570B8 (en) solid pharmaceutical composition suitable for oral administration, its use and its production process
CR20120283A (en) BENZODIAZEPINA BROMODOMINIUM INHIBITOR
ECSP088800A (en) DPP IV inhibitor formulations
ES2556585T3 (en) Compositions comprising salbutamol sulfate
BR112012010650A2 (en) release particle
AR060030A1 (en) DIESTERS OF RAMBED CARBOXYLIC ACIDS
CR20110078A (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES
MX2011007267A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
JOP20180077A1 (en) Synthetic bile acid compositions and methods
AR059742A1 (en) PHARMACEUTICAL FORMULATIONS OF AN ANHYDRA CRYSTAL FORM OF 2- (3- FLUOR-4- DIHYDROXIFENIL) 7- VINIL-1,3- BENZOXAZOL -5-OL
MY155611A (en) Curing agent composition
ECSP12012155A (en) HYDROCHLORIDE HYDROCHLORIDE HYDROCHLORIDE AND
CU20090200A7 (en) A COMPOSITION OF PROLONGED RELEASE THAT INCLUDES A SOMATOSTATIN DERIVATIVE IN MICROPARTS
EA201101118A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
BR112012015194A2 (en) cosmetic compositions of powder microspheres
BR112012009310B8 (en) compound derivatives of 2-oxo-1-pyrrolidinyl imidazothiadiazole, use thereof and pharmaceutical composition comprising them
BR112013024982A2 (en) collage compositions
BR112013027619A2 (en) curing process for concrete
BRPI1015042A2 (en) acid-labile triggering units
BR112012025857A2 (en) method for reducing at least one volatile organic component in a polymer composition
CL2008003711A1 (en) Process for preparing a pharmaceutical dosage form comprising florfenicol or an analog thereof; and to recover florfenicol or an analog of a pharmaceutical composition.
BR112012010075A2 (en) cosmetic composition comprising silicone saponin ester